Drug sensitivity and resistance testing (DSRT) of clinically important compounds on primary ovarian cancer cell lines.




Roering P, Mikkonen P, Potdar S, Wennerberg K, Hynninen J, Grenman S, Auranen A, Carpen O, Kaipio K

PublisherAMER ASSOC CANCER RESEARCH

2018

Clinical Cancer Research

CLINICAL CANCER RESEARCH

CLIN CANCER RES

24

15 suppl.

70

70

1

1078-0432

DOIhttps://doi.org/10.1158/1557-3265.OVCA17-A57




Last updated on 2024-26-11 at 23:41